17β-Estradiol, through activating the G protein-coupled estrogen receptor, exacerbates the complication of benign prostatic hyperplasia in type 2 diabetes mellitus patients by inducing prostate proliferation

• Main Authors: Tingting Yang (Author), Zhen Qiu (Author), Jiaming Shen (Author), Yutian He (Author), Longxiang Yin (Author), Li Chen (Author), Jiayu Yuan (Author), Junjie Liu (Author), Tao Wang (Author), Zhenzhou Jiang (Author), Changjiang Ying (Author), Sitong Qian (Author), Jinfang Song (Author), Xiaoxing Yin (Author), Qian Lu (Author)
• Format: Book
• Published: Elsevier, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Benign prostatic hyperplasia (BPH) is one of the major chronic complications of type 2 diabetes mellitus (T2DM), and sex steroid hormones are common risk factors for the occurrence of T2DM and BPH. The profiles of sex steroid hormones are simultaneously quantified by LC-MS/MS in the clinical serum o...